Axonics Modulation Technologies, Inc. - Special Call Transcript
Welcome to the Axonics Academy webinar series. My name is Karen Noblett and I am the Chief Medical Officer at Axonics Modulation Technologies and I'm very honored to moderate this webinar this evening. We are very excited for you to join us tonight to hear the first live presentation on the two-year ARTISAN clinical results.
This really represents a landmark study and it provides us the first look at long-term data on a rechargeable sacral neuromodulation system, mostly notably with the Axonics device. The ARTISAN two-year study provides us data on long-term clinical efficacy, patient safety, as well as patient experience. And again, we're very excited to share this data with you tonight.
Now, before we jump into the webinar itself, there's some important safety information that I'd like to share with you. This slide contains standard disclosures on indications, contraindications, precautions with the Axonics system. And if you are interested in learning more about the safety of the Axonics system, we encourage
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |